Cell therapies are already here, with treatments now available for some cancers and rare diseases. But bringing such living medicines to more patients presents both scientific and financial challenges ...
The Science Advances publication details Cellgorithmâ„¢, a CRISPR-based technology that gives researchers greater control over gene activity and sets the stage for future applications in stem cell ...
MONTRÉAL, March 31, 2026 /PRNewswire/ -- Syntax, a leading global technology solutions provider driving enterprise transformation in the cloud, today announced it has been named the recipient of an ...